Cell Source, Inc. (CLCS)
OTCMKTS: CLCS · Delayed Price · USD
0.0008
+0.0006 (300.00%)
Jul 25, 2024, 4:00 PM EDT - Market closed
Cell Source Market Cap
Cell Source has a market cap or net worth of $30.84 thousand as of July 26, 2024. Its market cap has decreased by -99.85% in one year.
Market Cap
30.84K
Enterprise Value
9.50M
1-Year Change
-99.85%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since July 30, 2019, Cell Source's market cap has decreased from $17.11M to $30.84K, a decrease of -99.82%. That is a compound annual growth rate of -71.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 30.55K | -99.83% |
| Dec 27, 2023 | 17.57M | -42.72% |
| Dec 29, 2022 | 30.67M | -30.35% |
| Dec 31, 2021 | 44.03M | -32.38% |
| Dec 31, 2020 | 65.11M | 108.95% |
| Dec 27, 2019 | 31.16M | 82.08% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 765.27B |
| Novo Nordisk | 575.53B |
| UnitedHealth Group | 524.43B |
| Johnson & Johnson | 386.61B |
| AbbVie | 326.97B |
| Merck & Co. | 317.39B |
| AstraZeneca | 242.25B |
| Thermo Fisher | 231.79B |